BackZhejiang Cheng Yi Pharmaceutical , Ltd. Overview

Zhejiang Cheng Yi Pharmaceutical , Ltd. Inventory

Track Zhejiang Cheng Yi Pharmaceutical , Ltd.'s inventory ($110M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$110.06M
↑ 5.07% YoYΔ $5.31M vs prior year quarter

Peer trimmed avg / median

Loading

Zhejiang Cheng Yi Pharmaceutical , Ltd. Inventory History

Loading

Zhejiang Cheng Yi Pharmaceutical , Ltd. vs. peers: Inventory Comparison

Loading

Zhejiang Cheng Yi Pharmaceutical , Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zhejiang Cheng Yi Pharmaceutical , Ltd. (603811.SS) FAQ

As of the most recent data (June 2026), 603811.SS shows a inventory of $110M. That compares with $100M in the prior-year period — up 5.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603811.SS's inventory is now $110M (was $100M) — a 5.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Zhejiang Cheng Yi Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 603811.SS's inventory over time shows whether Zhejiang Cheng Yi Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $100M in the prior-year period — up 5.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Zhejiang Cheng Yi Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $110M) with ownership activity and broader fundamentals.